Literature DB >> 15808404

Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer.

Mette Sørensen1, Herman Autrup, Anne Tjønneland, Kim Overvad, Ole Raaschou-Nielsen.   

Abstract

In a population-based case-cohort study, we have investigated the occurrence of lung cancer in relation to polymorphisms in the phase I gene cytochrome P450 1B1 and in the phase II genes glutathione S-transferase A1, NAD(P)H quinone oxidoreductase and N-acetyltransferase 2 (NAT2). Among 54,220 cohort members, 265 lung cancer cases were identified and a sub-cohort comprising 272 individuals was used for comparison. No overall associations were found between the polymorphisms and risk of lung cancer. The NAT2 fast acetylator genotype seemed to be protective against lung cancer in light smokers (< or =20 cigarettes/day) and not among heavy smokers (>20 cigarettes/day).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808404     DOI: 10.1016/j.canlet.2004.11.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.

Authors:  M L Cote; A S Wenzlaff; C H Bock; S J Land; S K Santer; D R Schwartz; A G Schwartz
Journal:  Lung Cancer       Date:  2006-12-15       Impact factor: 5.705

Review 2.  Pulmonary hypertension in women.

Authors:  Meredith E Pugh; Anna R Hemnes
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-11

3.  Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Wenhuan Xu; Yunhai Zhou; Xiaosheng Hang; Di Shen
Journal:  Mol Biol Rep       Date:  2011-06-15       Impact factor: 2.316

4.  Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.

Authors:  Catherine A Wassenaar; Qiong Dong; Qingyi Wei; Christopher I Amos; Margaret R Spitz; Rachel F Tyndale
Journal:  J Natl Cancer Inst       Date:  2011-07-11       Impact factor: 13.506

5.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

Review 6.  Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.

Authors:  Meredith E Pugh; Anna R Hemnes
Journal:  Womens Health (Lond)       Date:  2010-03

Review 7.  Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Xianjun Lao; Xue Qin; Qiliu Peng; Zhiping Chen; Yu Lu; Yanqiong Liu; Shan Li
Journal:  Lung       Date:  2014-07-03       Impact factor: 2.584

8.  CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women.

Authors:  Ya Li; Shi-Qiao Tan; Qian-Hong Ma; Lei Li; Zhong-Ying Huang; Yan Wang; Shang-Wei Li
Journal:  Tumour Biol       Date:  2013-06-23

9.  Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.

Authors:  E D Austin; J D Cogan; J D West; L K Hedges; R Hamid; E P Dawson; L A Wheeler; F F Parl; J E Loyd; J A Phillips
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

10.  NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.

Authors:  Yuqing Lou; Rong Li; Liwen Xiong; Aiqin Gu; Chunlei Shi; Tianqing Chu; Xueyan Zhang; Ping Gu; Hua Zhong; Shaojun Wen; Baohui Han
Journal:  Tumour Biol       Date:  2013-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.